logo
Churchill documents reveal D-Day landings boosted by import of ‘wonder drug' from America

Churchill documents reveal D-Day landings boosted by import of ‘wonder drug' from America

Yahoo2 days ago

Newly unearthed documents have revealed that the D-Day landings received a boost from the import of a "wonder drug" from America.
Despite its discovery in London in 1928 by Sir Alexander Fleming, large-scale production of the antibiotic penicillin had struggled to take hold in Britain.
Attempts to produce substantial quantities of medicine from the bacteria-killing mould had not been achieved by the start of the Second World War.
Then prime minister Sir Winston Churchill became increasingly frustrated that Britain had not been able to produce enough penicillin in the preparations for the Normandy landings in 1944.
Official papers released by the National Archive – containing handwritten notes by Sir Winston – highlight efforts to boost quantities of the antibiotic, with Britain eventually forced to import it from America.
The documents were released ahead of the 81st anniversary of D-Day, the Allied invasion of Normandy on June 6, 1944.
In one report on February 19, after the issue had been raised in the House of Commons, Sir Winston scrawled in red ink on a Ministry of Supply report noting the Americans were producing greater quantities: 'I am sorry we can't produce more.'
On another paper, he complained: 'Your report on penicillin showing that we are only to get about one tenth of the expected output this year, is very disappointing.'
Elsewhere in the same file he instructs: 'Let me have proposals for a more abundant supply from Great Britain.'
With preparations for D-Day ramped up, efforts to deliver enough American-made penicillin for frontline military personnel soon became a matter of urgency.
Decisions needed to be made on the quantities of antibiotic imported, how much to administer to individual patients, and how to get medical staff trained in time.
Most British doctors did not know how to issue penicillin – until this point, doctors had nothing available to treat infections like pneumonia and many people died of blood poisoning after minor injuries because no drug existed that could cure them.
Early in January 1944, Prof FR Fraser, the Ministry of Health's adviser on the organisation of wartime hospitals, wrote that 50,000-100,000 wounded could be expected from the Second Front.
He proposed the Emergency Medical Services might need as many as five billion units of penicillin per month for this.
Further documents show discussions on whether the antibiotic should be supplied as calcium or sodium salts, or in tablet form.
Ultimately, it was agreed powdered calcium salts would be issued for superficial wounds and sodium salts for use in deep wounds.
On May 24 1944, less than a fortnight before D-Day, Prof Fraser reported: 'Sufficient supplies of penicillin are now available for the treatment of battle casualties in EMS hospitals, but not for ordinary civilian patients.'
Plans were made for casualties from the frontline in France to be brought back to coastal hospitals in Britain for treatment.
A week before D-Day, on May 30 1944, hospitals were instructed to treat battlefield patients en route: 'In an endeavour to prevent the development of gas gangrene and sepsis in wounds the War Office have arranged for the treatment of selected cases by penicillin to be commenced as soon after injury as possible.'
Injections of penicillin were to be given to them at intervals of not more than five hours and patients would be wearing a yellow label with the letters 'PEN'. The time and size of penicillin doses should be written on it, they were told.
Dr Jessamy Carlson, modern records specialist at the National Archives, said: 'File MH 76/184 gives a glimpse into the extraordinary levels of preparation undertaken in advance of the D-Day landings.
'Only six weeks before, penicillin is just reaching our shores in quantities which will allow it to play a major role in improving the outcomes for service personnel wounded in action.'
As Allied forces made inroads into Europe, restrictions on the use of penicillin for civilians began to relax, but only in special cases.
In July 1944, Ronald Christie, professor of medicine, wrote to Prof Fraser to tell him: 'The War Office approves of American penicillin being used for medical conditions in service patients and for air raid casualties among civilians.'
On the home front, demand for the new 'wonder' drug began to increase, according the National Archives.
It was decided that penicillin for civilians should only be supplied to larger hospitals where the staff had been properly trained to administer it.
Only in 1946 did it become fully available for the general public.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Why Drug Price Reform Alone Won't Heal America
Why Drug Price Reform Alone Won't Heal America

Epoch Times

time6 hours ago

  • Epoch Times

Why Drug Price Reform Alone Won't Heal America

President Donald Trump's revived effort to reduce prescription drug prices is a long-overdue step toward affordability. For millions of Americans, the cost of staying alive has become burdensome, and any policy that eases the burden is worth celebrating. However, as a physician, I've seen what happens when medications become too cheap, plentiful, and automatic. If we don't reform how drugs are used, we risk trading financial hardship for clinical harm. Vagaries of Lower Drug Costs In today's health care system, medication is the first answer—and often the last, especially for older adults. More than 40

Measles resurgence highlights the toll of RFK Jr.'s anti-vaccine policies
Measles resurgence highlights the toll of RFK Jr.'s anti-vaccine policies

Yahoo

time9 hours ago

  • Yahoo

Measles resurgence highlights the toll of RFK Jr.'s anti-vaccine policies

After the U.S. surpassed 1,000 reported measles cases nationwide, it's clear the Trump administration is failing to protect our health and well-being. The measles outbreak in Texas is now the largest since 2000, when the country eliminated measles. And it's not yet over, threatening to make measles endemic in America again, where the risk of infection comes from within our country. Furthermore, two unvaccinated school-aged children in Texas died from measles, the first American children to die from the viral infection since 2003. Normally, a preventable infection causing avoidable deaths of children would lead to prompt government action. In 1991, I was a medical student with the U.S. Public Health Service in Philadelphia during a large measles outbreak. Over 1,000 people were infected, and nine children died. Government and public health leaders required home visits of infected children, mass immunization, education efforts and even court-mandated vaccinations. The outbreak was stopped. In Dec. 2014, a measles outbreak began at Disneyland and spread in communities with low vaccination rates. Public health action stopped this large outbreak at 125 cases. To prevent further outbreaks in California, I authored Senate Bill 277, which eliminated non-medical exemptions for school vaccines. And with further U.S. measles outbreaks in 2019, I authored Senate Bill 276 to crack down on fraudulent medical exemptions. These laws — championed by California parents demanding safe schools for children — raised statewide vaccination rates and shielded our communities. As Congress waits, Health and Human Services Secretary Robert F. Kennedy Jr. is dismantling decades of public health achievement that will make America sicker. Kennedy reduced vaccine outreach, removed key public health officials, spread disinformation from his official post and suppressed data while elevating conspiracy theorists to top positions. Kennedy and the Department of Government Efficiency fired a quarter of Health and Human Services staff, gutting the Centers for Disease Control and Prevention (CDC) and National Institutes of Health teams vital to outbreak response. He installed anti-vaccine extremists as advisors, including David Grier, a discredited researcher disciplined for unethical experiments on children with autism, to 'research' if vaccines cause autism, despite decades of research debunking this myth. The CDC has been muzzled: An analysis showing high rates of measles in low vaccination areas was suppressed, and dozens of Texas vaccination clinics were forced to close. When Kennedy dismantled the CDC's communication team, his former anti-vaccine organization, Children's Health Defense, filled the void with disinformation by publishing a fake CDC-branded vaccine 'safety' website that falsely linked vaccines to autism. The site mimicked official CDC design and branding, deliberately misleading the public. After news reports exposed the deception and forced the site's removal, no federal action has been taken to investigate or prosecute this unlawful impersonation of a federal agency. Furthermore, Dr. Peter Marks, the nation's top vaccine regulator who led President Donald Trump's Operation Warp Speed, refused a demand for false data on brain swelling and death caused by the Measles-Mumps-Rubella vaccine, of which there are no credible cases. Kennedy forced him to resign. In his resignation letter, Marks wrote, 'it has become clear that truth and transparency are not desired by the secretary, but rather he wishes subservient confirmation of his misinformation and lies.' And what of the dead children from measles? Kennedy dismissed the first measles death, saying 'it's not unusual.' He blamed measles on poor nutrition, called vaccines a 'personal choice' that could cause 'adverse events' and claimed Vitamin A and cod liver oil treated measles. Subsequently, many Texas children hospitalized with measles also had Vitamin A toxicity. At his first Congressional hearing, Kennedy testified, 'I don't think people should be taking medical advice from me.' He then refused to answer whether he would vaccinate a child against polio. As Health and Human Services secretary, he cravenly refuses to save Americans in a public health crisis. How many children must get sick — and even die — before Congress demands that Kennedy and the Trump administration answer for these preventable deaths and the continued spread of a preventable disease? This flu season, as flu vaccination declined, 226 children died from influenza — the highest since the 2009-10 pandemic. Other preventable and deadly diseases, including polio and whooping cough, will also return when vaccination is hampered and discouraged. Our state has made progress in raising vaccination rates, but we are not immune to Kennedy's dangerous vaccine disinformation; California has communities with enough unvaccinated people to fuel a serious outbreak. Measles outbreaks in other states makes it imperative that California strengthen our public health defenses against sparks of infection. And California needs Congress to hold President Donald Trump and Kennedy accountable for not stopping preventable disease in America. Dr. Richard Pan is a pediatrician and former California state senator who authored landmark legislation to eliminate non-medical exemptions to school vaccination requirements in response to major measles outbreaks.

Menopause drug might prevent breast cancer and treat hot flashes, research finds
Menopause drug might prevent breast cancer and treat hot flashes, research finds

New York Post

time10 hours ago

  • New York Post

Menopause drug might prevent breast cancer and treat hot flashes, research finds

A drug intended to treat menopause symptoms could double as breast cancer prevention. New research from Northwestern University in Illinois found that Duavee, a Pfizer-made drug, 'significantly reduced' breast tissue cell growth, which is a major indicator of cancer progression. Advertisement A phase 2 clinical trial included 141 post-menopausal women who had been diagnosed with ductal carcinoma in situ (DCIS), also known as stage 0 breast cancer, according to a press release from Northwestern. This non-invasive breast cancer affects more than 60,000 American women each year, often leading to an outcome of invasive breast cancer. The women were separated into two groups — one received Duavee and the other took a placebo for a month before undergoing breast surgery. Duavee is a conjugated estrogen/bazedoxifene (CE/BZA) drug, which combines estrogen with another medication that minimizes the potential harmful side effects of the hormone. Advertisement 'The key takeaway from the study is that CE/BZA slows the growth (proliferation) of cells in milk ducts of DCIS that expressed the estrogen receptor significantly more than placebo,' Dr. Swati Kulkarni, lead investigator and professor of breast surgery at Northwestern University Feinberg School of Medicine, told Fox News Digital. 5 New research from Northwestern University found that the drug Duavee 'significantly reduced' breast tissue cell growth, a major indicator of cancer progression. Marko Geber – Another major finding is that the quality of life did not differ significantly between the two groups, but patients who took the CE/BZA reported fewer hot flashes during the study, she noted. 'This would be expected, as the drug is FDA-approved to treat hot flashes.' Advertisement Kulkarni presented the study last week at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. 5 The women in the study were separated into two groups — one received Duavee and the other took a placebo for a month before undergoing breast surgery. Gorodenkoff – 5 Those who took the drug reported fewer hot flashes during the study. fizkes – The findings are preliminary and have not yet been published in a medical journal. Advertisement 'What excites me most is that a medication designed to help women feel better during menopause may also reduce their risk of invasive breast cancer,' said the doctor, who is also a Northwestern Medicine breast surgeon. Women who face a higher risk of breast cancer — including those who have experienced 'high-risk lesions' — and who also have menopausal symptoms are most likely to benefit from the drug, according to Kulkarni. 'These women are typically advised against standard hormone therapies, leaving them with few menopausal treatment options,' the release stated. Study limitations The researchers said they are 'encouraged' by these early results, but more research is required before the medication can be considered for approval as a breast cancer prevention mechanism. 'Our findings suggest that CE/BZA may prevent breast cancer, but larger studies with several years of follow-up are needed before we would know this for sure,' Kulkarni told Fox News Digital. Dr. Sheheryar Kabraji, chief of breast medicine at the Roswell Park Comprehensive Cancer Center in Buffalo, New York, was not involved in the study but commented on the findings. 5 'What excites me most is that a medication designed to help women feel better during menopause may also reduce their risk of invasive breast cancer,' Dr. Swati Kulkarni said. sarayutsridee – Advertisement 'While intriguing, this study is highly preliminary, and more research will be needed before we can conclude that conjugated estrogen/bazedoxifene (CD/BZA), a form of the hormone estrogen commonly prescribed to address symptoms of menopause, prevents invasive breast cancer or is effective at reducing cancer risk,' he told Fox News Digital. Kabraji also noted that the study focused on reducing levels of one specific protein, 'which does not always predict reduced recurrence of breast cancer.' 'This study did not directly show that CE/BZA treatment reduces the risk of DCIS recurrence or development of invasive cancer,' he noted. 5 According to Kulkarni,'larger studies with several years of follow-up are needed' to confirm that the drug prevents breast cancer. Science RF – Advertisement 'Importantly, however, patients who received this therapy experienced no worsening of quality of life, and saw improvement in vasomotor symptoms, such as hot flashes. If found to be effective in preventing breast cancer, CE/BZA is likely to have fewer side effects than current medications used for breast cancer prevention.' Lead researcher Kulkarni emphasized that this medication is not for the treatment of invasive breast cancer or DCIS. 'Right now, we can say that women who are concerned about their risk of developing breast cancer can consider this medication to treat their menopausal symptoms,' she added.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store